CONTI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.535
EU - Europa 1.331
AS - Asia 1.057
SA - Sud America 237
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.246
Nazione #
US - Stati Uniti d'America 2.499
SG - Singapore 333
CN - Cina 217
RU - Federazione Russa 208
UA - Ucraina 203
VN - Vietnam 198
IT - Italia 192
BR - Brasile 191
DE - Germania 154
SE - Svezia 153
IE - Irlanda 110
TR - Turchia 94
FR - Francia 74
DK - Danimarca 72
FI - Finlandia 59
CI - Costa d'Avorio 50
GB - Regno Unito 50
HK - Hong Kong 48
IN - India 40
KR - Corea 39
BD - Bangladesh 17
AR - Argentina 16
MX - Messico 16
CA - Canada 14
NL - Olanda 14
ZA - Sudafrica 13
PL - Polonia 12
IQ - Iraq 11
CO - Colombia 8
EC - Ecuador 8
ES - Italia 8
ID - Indonesia 8
JP - Giappone 8
MA - Marocco 7
PH - Filippine 6
BE - Belgio 5
EU - Europa 5
MY - Malesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
AT - Austria 4
EG - Egitto 4
LT - Lituania 4
JO - Giordania 3
LB - Libano 3
PK - Pakistan 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
IL - Israele 2
LY - Libia 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.246
Città #
Ashburn 416
Chandler 221
Jacksonville 212
Singapore 195
Fairfield 176
Dublin 110
New York 106
San Jose 106
Wilmington 101
Boardman 90
Dallas 84
Seattle 84
Woodbridge 84
Beijing 79
Ho Chi Minh City 69
Abidjan 50
The Dalles 49
Hong Kong 47
Houston 47
Cambridge 44
Lawrence 43
Princeton 43
San Mateo 43
Lauterbourg 41
Hanoi 38
Munich 37
Centro 36
Los Angeles 35
Moscow 34
Ann Arbor 31
San Diego 20
São Paulo 16
Da Nang 15
Hefei 15
London 15
Turku 15
Orem 14
Turin 14
Chennai 12
Brooklyn 11
Chicago 11
Helsinki 11
Warsaw 11
Guangzhou 10
Johannesburg 9
Pune 9
Rome 9
Buffalo 8
Des Moines 8
Marche 8
Rio de Janeiro 8
Santa Clara 8
Tokyo 8
Frankfurt am Main 7
Porto Alegre 7
Redmond 7
Shanghai 7
Stockholm 7
Haiphong 6
Manchester 6
Montegiorgio 6
Montreal 6
Poplar 6
Wuxi 6
Ancona 5
Brussels 5
Cupra Marittima 5
Hải Dương 5
Norwalk 5
Porto 5
Quận Ba 5
Thái Nguyên 5
Washington 5
Atlanta 4
Baghdad 4
Belo Horizonte 4
Brasília 4
Curitiba 4
Jiaxing 4
Mexico City 4
Mumbai 4
Naples 4
Nuremberg 4
Phoenix 4
San Francisco 4
Toronto 4
Amsterdam 3
Ankara 3
Biên Hòa 3
Boston 3
Cairo 3
Cape Town 3
Chiswick 3
City of London 3
Columbus 3
Guarulhos 3
Istanbul 3
Izmir 3
Kilburn 3
Miami 3
Totale 3.226
Nome #
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 194
Emerging biomarkers in bladder cancer identified by network analysis of transcriptomic data 178
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 177
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 168
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 164
Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience 158
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 156
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 153
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 152
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 152
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 149
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 148
Metabolic Alterations in Renal and Prostate Cancer 147
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 136
PEC-OME of the prostate: case report 135
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 130
Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience. 127
Biomarkers for VEGF-targeted therapy in renal cell carcinoma: an UpTo Date 127
Diagnostic-therapeutic pathway for small lesions of the testis 126
Present and future of personalized medicine in adult genitourinary tumors 126
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 125
NEPHRON-SPARING SURGERY FOR RENAL MASSES >4 CM (CT1B-T2) IN PATIENTS WITH CHRONIC RENAL FAILURE 120
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives. 119
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 117
Urinary catheters and biofilm formation 116
Sphincter: properties, types and application 116
Role of STAT3 pathway in genitourinary tumors 109
The route to personalized medicine in bladder cancer: where do we stand? 108
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma 107
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 107
Efficacy and safety of alfa-1-blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective study 105
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: A systematic review and meta-analysis 105
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 103
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 100
Recurrent urinary tract infections and dysfunctional voiding 99
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 99
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis 90
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 87
VEGF and HIF in renal cell carcinogenesis. 85
Survival in Patients with Clear Cell Renal Cell Carcinoma is Predicted by HIF-1α Expression 85
RESULTS OF NEPHRON-SPARING SURGERY WITHOUT VASCULAR CLAMPING IN PATIENTS WITH CHRONIC RENAL FAILURE 78
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors 76
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 65
Totale 5.324
Categoria #
all - tutte 24.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 82 73 37
2021/2022306 33 60 8 9 2 26 5 15 24 28 24 72
2022/2023636 58 94 44 48 48 53 3 40 168 8 48 24
2023/2024419 75 7 28 47 56 131 8 12 3 9 1 42
2024/2025710 101 53 11 10 54 22 62 21 145 43 87 101
2025/20261.773 169 141 80 182 256 144 317 214 166 104 0 0
Totale 5.324